La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « ISSN » - entrée « 0303-6995 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0303-2647 < 0303-6995 < 0303-8467  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000C35 (2009) Olga Corti ; Margot Fournier ; Alexis BriceNeurodegeneration in Parkinson's disease: genetics enlightens physiopathology.
000E98 (2006) E C HirschAltered regulation of iron transport and storage in Parkinson's disease.
000E99 (2006) Y. Agid ; M. Schüpbach ; M. Gargiulo ; L. Mallet ; J L Houeto ; C. Behar ; D. Maltête ; V. Mesnage ; M L WelterNeurosurgery in Parkinson's disease: the doctor is happy, the patient less so?
000F00 (2006) A L Benabid ; S. Chabardès ; E. Seigneuret ; V. Fraix ; P. Krack ; P. Pollak ; R. Xia ; B. Wallace ; F. SauterSurgical therapy for Parkinson's disease.
000F01 (2006) I. ArnulfSleep and wakefulness disturbances in Parkinson's disease.
000F02 (2006) G U Höglinger ; W H Oertel ; E C HirschThe rotenone model of parkinsonism--the five years inspection.
000F03 (2006) E C HirschHow to judge animal models of Parkinson's disease in terms of neuroprotection.
000F04 (2006) A. Lannuzel ; G U Höglinger ; P. Champy ; P P Michel ; E C Hirsch ; M. RubergIs atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?
001141 (2003) E C Hirsch ; G. Höglinger ; E. Rousselet ; T. Breidert ; K. Parain ; J. Feger ; M. Ruberg ; A. Prigent ; C. Cohen-Salmon ; J M LaunayAnimal models of Parkinson's disease in rodents induced by toxins: an update.
001433 (1999) E C HirschMechanism and consequences of nerve cell death in Parkinson's disease.
001434 (1999) B. Piallat ; A. Benazzouz ; A L BenabidNeuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
001435 (1999) O. RascolDopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?
001549 (1997) E C Hirsch ; B. Faucheux ; P. Damier ; A. Mouatt-Prigent ; Y. AgidNeuronal vulnerability in Parkinson's disease.
001649 (1995) J L Montastruc ; O. Rascol ; J M Senard ; G. Houin ; A. RascolSublingual apomorphine: a new pharmacological approach in Parkinson's disease?
001650 (1995) B. Dubois ; B. PillonDo cognitive changes of Parkinson's disease result from dopamine depletion?
001693 (1994) J C Delumeau ; D. Bentué-Ferrer ; J M Gandon ; R. Amrein ; S. Belliard ; H. AllainMonoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases.
001743 (1993) F. Javoy-AgidParkinson's Disease Brain Bank in Paris: an evolutive bank responding to the exigencies of new neurochemical methodologies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/ISSN.i -k "0303-6995" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/ISSN.i  \
                -Sk "0303-6995" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0303-6995
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024